Search Results

There are 15958 results for: content related to: Satellite dialysis nursing: technology, caring and power

  1. The effect of renal disease on the disposition of venlafaxine

    Clinical Pharmacology & Therapeutics

    Volume 56, Issue 1, July 1994, Pages: 14–21, Steven M Troy, Robert W Schultz, Vernon D Parker, Soong T Chiang and Robert A Blum

    Article first published online : 3 JUL 1994, DOI: 10.1038/clpt.1994.95

  2. Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: A multicentre, open-label, Australian study

    Nephrology

    Volume 12, Issue 1, February 2007, Pages: 95–101, ALEX DISNEY, PETER DE JERSEY, GEOFF KIRKLAND, MURTY MANTHA, JOHN A CHARLESWORTH, MARTIN GALLAGHER, DAVID HARRIS, HILTON GOCK, GEORGE J MANGOS, JAMIE MACMILLAN, WEI LIU and AJIT VISWALINGAM

    Article first published online : 8 FEB 2007, DOI: 10.1111/j.1440-1797.2006.00757.x

  3. The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study

    Nephrology

    Volume 20, Issue 3, March 2015, Pages: 140–147, Matthew A Roberts, Helen L Pilmore, Francesco L Ierino, Sunil V Badve, Alan Cass, Amit X Garg, Carmel M Hawley, Nicole M Isbel, Henry Krum, Elaine M Pascoe, Andrew M Tonkin, Liza A Vergara, Vlado Perkovic and for theBLOCADE Study Collaborative Group

    Article first published online : 24 FEB 2015, DOI: 10.1111/nep.12362

  4. Oral Iron for Patients Receiving Dialysis: What is the Evidence?

    Seminars in Dialysis

    Volume 27, Issue 1, January–February 2014, Pages: 8–10, Elisabeth M. Hodson and Jonathan C. Craig

    Article first published online : 9 JAN 2014, DOI: 10.1111/sdi.12149

  5. You have free access to this content
    An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis

    Journal of Internal Medicine

    Volume 260, Issue 6, December 2006, Pages: 577–585, A. K. AGARWAL, M. R. SILVER, J. E. REED, R. K. DHINGRA, W. LIU, N. VARMA and C. STEHMAN-BREEN

    Article first published online : 16 NOV 2006, DOI: 10.1111/j.1365-2796.2006.01723.x

  6. Alkaline phosphatase predicts calcium requirements after total parathyroidectomy in patients receiving dialysis

    British Journal of Surgery

    Volume 97, Issue 2, February 2010, Pages: 185–188, B. L. Goh, M. G. Yudisthra and A. N. Hisham

    Article first published online : 24 DEC 2009, DOI: 10.1002/bjs.6818

  7. Darbepoetin alfa, a New Therapy for the Management of Anemia of Chronic Kidney Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 9P2, September 2002, Pages: 141S–149S, Joanna Q. Hudson and Roya M. Sameri

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.22.14.141S.33397

  8. Effect of pyridoxine supplementation on plasma oxalate concentrations in patients receiving dialysis

    European Journal of Clinical Investigation

    Volume 19, Issue 2, April 1989, Pages: 201–205, C. R. V. TOMSON, SUSAN M. CHANNON, I. S. PARKINSON, W. S. SHELDON, M. K. WARD and M. K. LAKER

    Article first published online : 20 MAR 2008, DOI: 10.1111/j.1365-2362.1989.tb00218.x

  9. You have free access to this content
    Cardiovascular disease in patients with chronic kidney disease

    Nephrology

    Volume 19, Issue 1, January 2014, Pages: 3–10, Helen Pilmore, Gursharan Dogra, Matthew Roberts, Hiddo J Lambers Heerspink, Toshiharu Ninomiya, Rachel Huxley and Vlado Perkovic

    Article first published online : 17 DEC 2013, DOI: 10.1111/nep.12148

  10. Phosphodiesterase Type 5 Inhibitor Treatment for Erectile Dysfunction in Patients with End-Stage Renal Disease Receiving Dialysis or After Renal Transplantation

    The Journal of Sexual Medicine

    Volume 10, Issue 11, November 2013, Pages: 2798–2814, Fedele Lasaponara, Omid Sedigh, Giovanni Pasquale, Andrea Bosio, Luigi Rolle, Carlo Ceruti, Massimiliano Timpano, Carlo Luigi Augusto Negro, Matteo Paradiso, Annamaria Abbona, Giuseppe Paolo Segoloni and Dario Fontana

    Article first published online : 24 JAN 2013, DOI: 10.1111/jsm.12038

  11. Cardiac troponin levels in asymptomatic patients on the renal transplant waiting list

    Nephrology

    Volume 11, Issue 5, October 2006, Pages: 471–476, MATTHEW A ROBERTS, NEIL MACMILLAN, DAVID L HARE, SUJIVA RATNAIKE, KEN SIKARIS, MARGARET B FRAENKEL and FRANCESCO L IERINO

    Article first published online : 29 SEP 2006, DOI: 10.1111/j.1440-1797.2006.00661.x

    Corrected by:

    Corrigendum

    Vol. 12, Issue 2, 208, Article first published online: 8 FEB 2007

    Corrected by:

    Corrigendum

    Vol. 12, Issue 2, 207, Article first published online: 16 MAR 2007

  12. The Pharmacokinetics of Enoxaparin Do Not Correlate With Its Pharmacodynamic Effect in Patients Receiving Dialysis Therapies

    The Journal of Clinical Pharmacology

    Volume 46, Issue 8, August 2006, Pages: 887–894, Dr Donald F. Brophy, Dr Marcus E. Carr Jr, Ms Erika J. Martin, Dr Jürgen Venitz and Dr Todd W. B. Gehr

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006289975

  13. Health numeracy: Perspectives about using numbers in health management from African American patients receiving dialysis

    Hemodialysis International

    Volume 19, Issue 2, April 2015, Pages: 287–295, Julie A. Wright Nunes, Chandra Y. Osborn, T. Alp Ikizler and Kerri L. Cavanaugh

    Article first published online : 30 OCT 2014, DOI: 10.1111/hdi.12239

  14. Antimicrobial Agents

    Seminars in Dialysis

    Volume 23, Issue 5, September/October 2010, Pages: 472–474, Darren W. Grabe

    Article first published online : 29 OCT 2010, DOI: 10.1111/j.1525-139X.2010.00774.x

  15. Bromfenac disposition in patients with impaired kidney function

    Clinical Pharmacology & Therapeutics

    Volume 61, Issue 3, March 1997, Pages: 312–318, James C. Ermer, Joseph P. Boni, William H. Cevallos, Sheryl DeCleene, Peter Burghart, Michael R. Rudnick, Richard J. Fruncillo, Jeffrey S. Berns and Raphael M. Cohen

    Article first published online : 10 MAR 1997, DOI: 10.1016/S0009-9236(97)90163-6

  16. Salsalate kinetics in patients with chronic renal failure undergoing hemodialysis

    Clinical Pharmacology & Therapeutics

    Volume 39, Issue 4, April 1986, Pages: 420–424, Mark E Williams, Michael Weinblatt, Robert M Rosa, Victoria L Griffin, M Barry Goldlust, Shaw F Shang, Lester I Harrison and Robert S Brown

    Article first published online : 18 APR 1986, DOI: 10.1038/clpt.1986.65

  17. Relationship Between Renal Function and Extracorporeal Membrane Oxygenation Use: A Single-Center Experience

    Artificial Organs

    Volume 39, Issue 4, April 2015, Pages: 369–374, Punkaj Gupta, Jacob Carlson, Dennis Wells, Patrick Selakovich, Michael J. Robertson, Jeffrey M. Gossett, Eudice E. Fontenot and Matthew B. Steiner

    Article first published online : 8 OCT 2014, DOI: 10.1111/aor.12379

  18. The effect of renal disease on tolrestat pharmacokinetics

    Clinical Pharmacology & Therapeutics

    Volume 51, Issue 3, March 1992, Pages: 271–277, Steven M Troy, David R Hicks, Michael Kraml, Kenneth Conrad and Soong T Chiang

    Article first published online : 27 MAR 1992, DOI: 10.1038/clpt.1992.22

  19. Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis

    The Journal of Clinical Pharmacology

    Volume 50, Issue S9, September 2010, Pages: 75S–90S, Sameer Doshi, Andrew Chow and Juan José Pérez Ruixo

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010377201

  20. Alprazolam in end-stage renal disease. II. Pharmacodynamics

    Clinical Pharmacology & Therapeutics

    Volume 51, Issue 5, May 1992, Pages: 533–540, Virginia D Schmith, Beth Piraino, Randall B Smith and Patricia D Kroboth

    Article first published online : 18 MAY 1992, DOI: 10.1038/clpt.1992.59